Overview
- Provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context
- Surveys the biology STAT family of transcription factors and their role in cancer etiology
- Covers the full spectrum of therapeutic approaches to inhibiting STATS, while presenting the emerging data from clinical trials
- Includes supplementary material: sn.pub/extras
Part of the book series: Cancer Drug Discovery and Development (CDD&D)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (7 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.
Editors and Affiliations
About the editor
Bibliographic Information
Book Title: STAT Inhibitors in Cancer
Editors: Alister C. Ward
Series Title: Cancer Drug Discovery and Development
DOI: https://doi.org/10.1007/978-3-319-42949-6
Publisher: Humana Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-42947-2Published: 17 October 2016
Softcover ISBN: 978-3-319-82701-8Published: 16 June 2018
eBook ISBN: 978-3-319-42949-6Published: 08 October 2016
Series ISSN: 2196-9906
Series E-ISSN: 2196-9914
Edition Number: 1
Number of Pages: VII, 195
Number of Illustrations: 11 illustrations in colour
Topics: Cancer Research